Status:
COMPLETED
Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy
Lead Sponsor:
Mid Atlantic Retina
Conditions:
Macular Hole
Retinal Detachment
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to see if glaucoma eye drops (dorzolamide-timolol) have any effect on the duration of an intraocular gas bubble following pars plana vitrectomy.
Detailed Description
At the end of some retinal surgeries, a gas bubble is placed in the eye. In surgeries for retinal detachment, this gas bubble helps to keep the tear(s) in the retina sealed up while the eye is healing...
Eligibility Criteria
Inclusion
- Patients scheduled for pars plana vitrectomy with intraocular gas tamponade with sulfur hexafluoride (e.g., retinal detachment, macular hole, other condition at the discretion of the investigator).
- Ability to provide written informed consent and comply with study assessments for the full duration of the study.
Exclusion
- Prior trabeculectomy or tube shunt surgery.
- Current use of topical aqueous suppressants or other glaucoma medications.
- Aphakia or presence of anterior chamber intraocular lens implant.
- Known allergy or contraindication to sulfa or beta-blocker use (e.g., asthma, chronic obstructive pulmonary disease, bradycardia).
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01257698
Start Date
February 1 2010
End Date
June 1 2013
Last Update
September 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wills Eye Institute
Philadelphia, Pennsylvania, United States, 19107